Gruber Peter J, Epstein Jonathan A
Cardiac Center, Children's Hospital of Philadelphia, Pa, USA.
Circ Res. 2004 Feb 20;94(3):273-83. doi: 10.1161/01.RES.0000116144.43797.3B.
Significant advances in the understanding of the molecular and genetic basis of congenital heart disease have emerged from gene inactivation studies in mice and from human genetic investigations. However, the ability to utilize information gleaned from animal models to inform clinical care of patients depends on an accurate anatomic analysis and presentation in terms that are meaningful to the clinical pediatric cardiologist. Likewise, the enormous depth and breadth of accumulated clinical experience can inform the developmental biologist and can highlight the importance and interrelationships of particular phenotypes. The explosion of potentially informative genetic tools demands that basic scientists and clinicians concerned with congenital cardiac disease enhance the ongoing bidirectional dialogue. In some cases, categories of congenital disease familiar to clinicians are not recognized by developmental biologists, and mechanisms accepted by the biologist seem inconsistent with clinical experience. In this review, we summarize some of the more clinically significant forms of congenital heart disease, and we highlight relevant genetic and developmental pathways.
对先天性心脏病分子和遗传基础的理解取得了重大进展,这源于小鼠基因失活研究和人类遗传学调查。然而,利用从动物模型中收集的信息为患者临床护理提供依据的能力,取决于对解剖结构的准确分析以及以对临床儿科心脏病专家有意义的方式呈现。同样,积累的临床经验的巨大深度和广度可以为发育生物学家提供信息,并突出特定表型的重要性和相互关系。大量潜在的信息丰富的遗传工具的出现,要求关注先天性心脏病的基础科学家和临床医生加强正在进行的双向对话。在某些情况下,临床医生熟悉的先天性疾病类别未被发育生物学家认可,而生物学家认可的机制似乎与临床经验不一致。在本综述中,我们总结了一些临床上更重要的先天性心脏病形式,并强调了相关的遗传和发育途径。